Cargando…
Testing for heterogeneity among the components of a binary composite outcome in a clinical trial
BACKGROUND: Investigators designing clinical trials often use composite outcomes to overcome many statistical issues. Trialists want to maximize power to show a statistically significant treatment effect and avoid inflation of Type I error rate due to evaluation of multiple individual clinical outco...
Autores principales: | Pogue, Janice, Thabane, Lehana, Devereaux, PJ, Yusuf, Salim |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909251/ https://www.ncbi.nlm.nih.gov/pubmed/20529275 http://dx.doi.org/10.1186/1471-2288-10-49 |
Ejemplares similares
-
Designing and Analyzing Clinical Trials with Composite Outcomes: Consideration of Possible Treatment Differences between the Individual Outcomes
por: Pogue, Janice, et al.
Publicado: (2012) -
Assessment and Implication of Prognostic Imbalance in Randomized Controlled Trials with a Binary Outcome – A Simulation Study
por: Chu, Rong, et al.
Publicado: (2012) -
Canadian-led capacity-building in biostatistics and methodology in cardiovascular and diabetes trials: the CANNeCTIN Biostatistics and Methodological Innovation Working Group
por: Thabane, Lehana, et al.
Publicado: (2011) -
Imputation strategies for missing binary outcomes in cluster randomized trials
por: Ma, Jinhui, et al.
Publicado: (2011) -
Comparison of population-averaged and cluster-specific models for the analysis of cluster randomized trials with missing binary outcomes: a simulation study
por: Ma, Jinhui, et al.
Publicado: (2013)